Metaboost Tirzepatide Review: Starting Offer and Conflicting Terms

Metaboost Rx advertises a named compounded tirzepatide injection program from $149 per month, displayed alongside a higher $249 amount. Its product page describes a flat-rate care package with clinician-directed dosing, messaging and follow-up.¹²

The important limit is that the starting offer does not establish a complete dose, supply or renewal quote. A second material issue is conflicting cancellation language: the product FAQ describes 30 days' notice, while the terms describe a 48-hour auto-refill cutoff.²³ This review examines public information without buying treatment or testing the service.

A named program with continuing care

The current product page identifies tirzepatide and describes compounded medication, an assigned provider, dose adjustments, portal messaging, check-ins and delivery. It says the quoted flat rate does not add consultation or dose-change surcharges.²

These are provider descriptions, not independent measurements of care quality or outcomes. Ask how often reviews occur, who answers a clinical question between them and whether the proposed prescription changes the payment arrangement. A clinical concern should not be routed only through administrative customer support.

The platform and independent clinical practitioners have different responsibilities. Obtain the actual treating practice and clinician details before treatment. The existence of a polished branded program does not establish individual licensure or a particular patient's clinical suitability.

Interpret $149 as a starting offer

The homepage assigns a $149 monthly starting amount to tirzepatide. It does not establish which dose, quantity, term or patient circumstances produce that price, or whether the higher adjacent amount represents the later renewal rate.¹ We do not invent a lifetime all-dose quote from that display.

Request the first charge and subsequent charge, prescribed weekly milligrams, total medication, number of shipments and any minimum financial term. If an initial discount ends, ask for the date and amount of the change. A platform's broad flat-rate claim and a promotional starting figure need to be reconciled in one written offer.

Also confirm supplies, shipping, clinical reviews and laboratory work. A monthly equivalent for a longer plan is different from an individually purchased month, especially if medicine is delivered in a larger starter shipment.

Cancellation rules disagree

The product FAQ says membership cancellation requires 30 days' notice before the next billing cycle. The terms say auto-refill can be disabled up to 48 hours before monthly processing and describe recurring charges every 30 days.²³

Neither deadline should be silently discarded. Ask which provision applies to your selected plan and obtain the exact next processing date. A patient prioritizing flexibility needs an answer before paying, not after a cancellation request is disputed.

If the purchase involves installments, ask whether disabling medication refills also ends remaining payment obligations. Save the accepted contract and written confirmation of any change. Billing, prescription authorization and physical delivery can occur on different dates.

Initial orders and medication problems

The terms describe an initial cancellation request within 24 hours, conditional on the order not yet reaching the provider network. They say dispensed or delivered prescription medicine is not refundable and describe particular refund circumstances rather than a general satisfaction guarantee.³

For incorrect or damaged items, the terms request contact within 48 hours of delivery and documentation of the problem. They also describe a disposal fee for returned prescription medicine.³ Confirm the applicable process and do not assume unused medicine can simply be returned to recover its price.

Ask separately what happens after initial medical denial, an unshipped order, a later change in clinical eligibility or a dose adjustment. Canceling future service and refunding an existing prescription are different questions.

Pharmacy and state details remain individual

The program refers to U.S. compounding partners and state-dependent clinical services but did not establish the actual dispenser or a definitive medication-specific state list for an individual buyer.²³ Ask about your location, then obtain the pharmacy name, contact details and dispensing authorization.

FDA states compounded GLP-1 medicines are not FDA-approved and do not undergo premarket review for safety, effectiveness or quality.⁴ Trial outcomes from approved injectable tirzepatide are not proof of a particular compound's results or the platform's clinical performance. Ask the prescriber to discuss appropriate approved alternatives.

Our assessment

Metaboost provides a named current offer and useful published contract information. Its dose-specific economics and conflicting cancellation provisions are the deciding gaps. Resolve both in writing rather than choosing on the $149 headline alone.

Compare other provider programs, the care-options guide and approved Zepbound costs using the complete prescription, payment commitment and follow-up needs.

To compare which renewal rule applies when public terms differ, see Ambiante and PrescrYbe.